I have learned to be patient with this stock. Sooner or later ANDAs will be approved and more revenue will be coming in. Rexista and PODRAS will take time. But I can tell you one thing, some BIG companies are taking a serious look at this stuff right now... I think it's IPCI's goal to license the PODRAS technology to multiple companies though. However, I don't think they would turn down a large buyout offer as well. I think over the next couple months we will see 1 or 2 ANDAs approved as well as more news on Rexista and PODRAS. Possibly even partnership news on Rexista.
Well said. Many more important things in life like fishing. Went last week looking for a giant. Was very slow. Lost a nice one the last hour of the trip right next to boat. Only chance I had all week but still had a great time. I am still holding CYTR long. My big bet is on IPCI and is worth a look if anyone is interested. Their PODRAS technology could be a game changer.
Someday Adam F will get what he is due. His articles are the signal for shorts to come together and pile on. To think he does this without monetary gain is ridiculous. He likes to spout off he is a journalist. But he is nothing more than a small fry that with the aid of his buddies can take down biotech microcaps. In my opinion, someday we will read that he has been charged and convicted for SEC violations.
As was said, these are the same ambulance chasers that go after every company. They throw #$%$ at the wall and see if anything sticks. With as high as the short interest is in CYTR, you have to wonder why all these legal PRs pile on at the same time. Sure looks like a concerted effort to force price down for short covering.
I have a 52.5, 49.75, 49.25 and a guy I took out got a really fat 50.5 and 50 in my boat. I am hoping to get a monster yet this fall. How about you, any fish?
I agree with your idea for a test plan. That should work. Maybe even have the strength of initial test pills be a lower dosage so they can give someone many, many pills without the risk of overdose. And yes if this technology can be proven to work, I do think they will have many suitors trying to buy IPCI. Market cap would be at least 1B. Hopefully, they don't have to sell to many more shares to accomplish this.
The value of this stock is in STS and other applications that Dox has. Aldo could replace Dox in many if not all applications based on reduced cardio-toxicity and the potential for people to tolerate more doses. The way things have progressed with GBM, I would be very, very surprised to see GBM turn into potential application.
Samsa- What is your estimate for current cash on hand and how long they can maintain at current rate of burn? Thanks.